A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10
Clinical trial NCT02482441 · COMPLETED
Trial details
- NCT number
- NCT02482441
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-16
- Primary completion
- 2018-01-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.